Lifeng Li

2PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 15, 2026
A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma.

|Jan 06, 2025
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysis.

Jie Dai, Tianxiao Xu, Lifeng Li

Pageof 1

Frequent Collaborators

2 joint publications

Lu Si

1 joint publications

Jing Lin

1 joint publications

Yu Chen

1 joint publications

Yan Kong